Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Ceralasertib
Refractory Malignant Neoplasm
National Cancer Institute (NCI)P2CCC (53)
CIS-DIAMMINEDICHLOROPLATINUM II
Combined Hepatocellular Carcinoma And Cholangiocarcinoma
National Cancer Institute (NCI)P2CCC (53)
CIS-DIAMMINEDICHLOROPLATINUM II
Lung Superior Sulcus Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Cobimetinib
Bile Duct Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Cobimetinib
Gallbladder Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Cobimetinib
Intrahepatic Cholangiocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Cobimetinib
Extrahepatic Bile Duct Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Cobimetinib
Distal Biliary Tract Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Cobimetinib
Gallbladder Cancer
National Cancer Institute (NCI)P2CCC (53)
Cobimetinib
Lung Cancer
National Cancer Institute (NCI)P2CCC (53)
Cobimetinib
Hepatocellular Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Copanlisib
Lymphoma
National Cancer Institute (NCI)P2CCC (53)
Copanlisib
Her2-Receptor Negative Breast Cancer
National Cancer Institute (NCI)P2CCC (53)
Copanlisib
Ovarian Serous Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Copanlisib
Fallopian Tube Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Copanlisib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Copanlisib
Primary Peritoneal Serous Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Cpx-351
Acute Myeloid Leukemia With Multilineage Dysplasia
National Cancer Institute (NCI)P2CCC (53)
Crizotinib
Lymphoma
National Cancer Institute (NCI)P2CCC (53)
Crizotinib
Urinary Bladder Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Crizotinib
Breast Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Crizotinib
Cervical Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Crizotinib
Colon Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Crizotinib
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Crizotinib
Carcinoma Of Esophagus
National Cancer Institute (NCI)P2CCC (53)
Showing 1176 to 1200 of 3,272 assets
PreviousPage 48 of 131Next